More in Pharma/Device Regs

Hear meeting, procurement, and hotel professionals discuss how the tough economy is affecting their business models at the Second Annual Medical Device and Bio/Pharmaceutical Meeting Management Forum...More

The American Medical Association did not approve a proposal by the Council on Ethical and Judicial Affairs to eliminate commercial support from CME, but the proposal could return in another form next year....More

It's no longer a question of whether commercial support will be eliminated -- the question is when -- and how stakeholders will accept the transition....More

How to use case studies to boost attendee involvement before, during, and after your meeting...More

The Association of American Medical Colleges approved stricter CME rules and a ban on gifts to physicians from industry...More

Get ready to prove yourself. Pfizer's new CME approach has three major goals: to fund only providers that meet high standards for compliance and independence; to support performance-improvement education that results in measurable changes in physician behavior and patient care; and to redirect resources from national programs to local and regional initiatives. And medical education and communication companies need not apply....More

Drawing nearly 200 attendees, the first annual West Coast Medical Device and Bio/Pharmaceutical Meeting Planners Forum—which took place December 10 to11 at the Hilton Orange County in Costa Mesa, Calif.—brought meeting planners and suppliers together to learn effective strategies for planning meetings that comply with the evolving legal and regulatory environment of the pharmaceutical industry....More

In a development that surprised many CME professionals, the Accreditation Council for CME issued an FAQ document prohibiting providers from asking commercial...More

The buzz at the Annual Conference of the National Task Force on CME Provider/Industry Collaboration, held in October, was all about the FAQ document the...More

More time, more money, more frustration. As CME providers know all too well, pharmaceutical companies' new grant application processes, created in response...More

CME/Industry Relations I read with interest the article ACCME Draws the Line (September/October 2007, page 9). You did a nice job bringing to light some...More